Population
Ambulatory high-risk cancer patients with solid tumors undergoing chemotherapy in the United States
Design
Cohort
Authors
Loading...
Supports consideration of targeted thromboprophylaxis in high-risk ambulatory cancer patients; extends observational data but leaves open randomized confirmation.
This study highlights the high real-world incidence of VTE in high-risk ambulatory cancer patients undergoing chemotherapy, emphasizing the potential benefit of targeted thromboprophylaxis.
Khorana et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: